J Zundler1, J C Bode. 1. Zentrum für Innere Medizin, Schwerpunkte Gastroenterologie, Hepatologie und Endokrinologie, Robert-Bosch-Krankenhaus, Stuttgart.
Abstract
BACKGROUND: Since the beginning of the eighties systematic investigations broadened our knowledge about the clinical picture of spontaneous bacterial peritonitis very much. Important insights into epidemiology, pathogenesis, symptomatology, diagnosis and therapy of this disease, which is a frequent complication in patients with cirrhosis of the liver and ascites, could be gained. Actual research work primarily deals with questions of therapy and prophylaxis. AIM: Aim of this review is a comprehensive presentation of the different aspects of this disease on the basis of the present literature. CONCLUSIONS: As on the one side the clinical symptoms may be very little and on the other side the prognosis is very bad, it is extremely important to take this entity into the differential considerations to make an early diagnosis and to start an adequate therapy early.
BACKGROUND: Since the beginning of the eighties systematic investigations broadened our knowledge about the clinical picture of spontaneous bacterial peritonitis very much. Important insights into epidemiology, pathogenesis, symptomatology, diagnosis and therapy of this disease, which is a frequent complication in patients with cirrhosis of the liver and ascites, could be gained. Actual research work primarily deals with questions of therapy and prophylaxis. AIM: Aim of this review is a comprehensive presentation of the different aspects of this disease on the basis of the present literature. CONCLUSIONS: As on the one side the clinical symptoms may be very little and on the other side the prognosis is very bad, it is extremely important to take this entity into the differential considerations to make an early diagnosis and to start an adequate therapy early.
Authors: S Kaymakoglu; H Eraksoy; A Okten; K Demir; S Calangu; Y Cakaloglu; G Boztas; F Besisik Journal: Eur J Gastroenterol Hepatol Date: 1997-01 Impact factor: 2.566
Authors: N Rolando; A Gimson; J Philpott-Howard; M Sahathevan; M Casewell; E Fagan; D Westaby; R Williams Journal: J Hepatol Date: 1993-07 Impact factor: 25.083
Authors: J M Salmerón; L Titó; A Rimola; A Mas; M A Navasa; J Llach; A Ginès; P Ginès; V Arroyo; J Rodés Journal: J Hepatol Date: 1992-03 Impact factor: 25.083